AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12504937 — intervention group
Group type: EXPERIMENTAL
Intervention: Nulliparity
Number of subjects: 15253
Study 12504937 — intervention group
Group type: COMPARATOR
Intervention: Education, age at menarche, oral contraceptive use, smoking habits
Number of subjects: 15253
Study 9507749 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacine 250 mg every 12 hours for 14 days (n = 7)
Number of subjects: 13
Study 9507749 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim 160 mg and sulfamethoxazole 800 mg every 12 hours for 14 days (n = 6)
Number of subjects: 13
Study 7896975 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to a distinctive stimulus before each chemotherapy infusion)
Number of subjects: 0
Study 7896975 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 2617619 — intervention group
Group type: EXPERIMENTAL
Intervention: Maloprim
Number of subjects: 1049
Study 2617619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1049
Study 2617619 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis
Number of subjects: 1049
Study 2617619 — intervention group
Group type: COMPARATOR
Intervention: No chemoprophylaxis
Number of subjects: 1049
Study 346617 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg diazepam per day
Number of subjects: 40
Study 346617 — intervention group
Group type: COMPARATOR
Intervention: Identical placebos
Number of subjects: 40
Study 31944827 — intervention group
Group type: EXPERIMENTAL
Intervention: Eclipse™
Number of subjects: 31
Study 31944827 — intervention group
Group type: COMPARATOR
Intervention: PSI-Plan
Number of subjects: 31
Study 31944827 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 31
Study 29735877 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skill training program for caregivers delivered in 4-hour sessions over 6 weeks
Number of subjects: 34
Study 29735877 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 34
Study 29735877 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skill training program for caregivers
Number of subjects: 34
Study 28373021 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue soup
Number of subjects: 12
Study 28373021 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow soup
Number of subjects: 12
Study 28373021 — intervention group
Group type: COMPARATOR
Intervention: White soup
Number of subjects: 12
Study 26048176 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day intensive mindfulness meditation training
Number of subjects: 35
Study 26048176 — intervention group
Group type: COMPARATOR
Intervention: 3-day relaxation training intervention without a mindfulness component
Number of subjects: 35
Study 23929924 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (losartan or telmisartan)
Number of subjects: 567
Study 20739446 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year food and physical activity intervention (14 group sessions)
Number of subjects: 92
Study 20739446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no group sessions)
Number of subjects: 92
Study 19099641 — intervention group
Group type: EXPERIMENTAL
Intervention: Haploidentical group (PBSCT combined with BMT)
Number of subjects: 24
Study 19099641 — intervention group
Group type: COMPARATOR
Intervention: HLA matched group (PBSCT regime)
Number of subjects: 24
Study 19099641 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ cell dose > 2 x 10^6/kg
Number of subjects: 24
Study 19099641 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+CD61+ cells infused in haploidentical patients
Number of subjects: 24
Study 19099641 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+CD61+ cells infused in HLA matched patients
Number of subjects: 24
Study 19099641 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ cells infused in total 20 patients
Number of subjects: 24
Study 15684204 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient care with oral levofloxacin therapy
Number of subjects: 224
Study 15684204 — intervention group
Group type: COMPARATOR
Intervention: Hospitalization with sequential intravenous and oral levofloxacin therapy
Number of subjects: 224
Study 12850904 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed diazepam tapering regime
Number of subjects: 44
Study 12850904 — intervention group
Group type: COMPARATOR
Intervention: Symptom-triggered taper method (diazepam only in response to withdrawal symptoms)
Number of subjects: 44
Study 12850904 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Fixed and Symptom-triggered)
Number of subjects: 44
Study 10229153 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Low Intensity Laser Therapy/Phototherapy (CLILT) (660-950 nm; 11 J/cm2; pulsed at 73 Hz)
Number of subjects: 36
Study 10229153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10229153 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 8896850 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Burst Stimulation (DBS2,3)
Number of subjects: 40
Study 1720843 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 10
Study 1720843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7156877 — intervention group
Group type: EXPERIMENTAL
Intervention: Instillation of 0.1 N HCl (2.5, 5, 10, and 15 ml volumes)
Number of subjects: 8
Study 7156877 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous reflux episodes
Number of subjects: 8
Study 30612797 — intervention group
Group type: EXPERIMENTAL
Intervention: Powdered 0.5% chlorhexidine acetate-based postmilking teat dip (PD)
Number of subjects: 331
Study 30612797 — intervention group
Group type: COMPARATOR
Intervention: Foamed 1% iodine-based postmilking teat dip (ID)
Number of subjects: 331
Study 28419747 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg daprodustat
Number of subjects: 55
Study 28419747 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg daprodustat
Number of subjects: 55
Study 28419747 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg moxifloxacin
Number of subjects: 55
Study 28419747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 26007314 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ibuprofen (20-10-10 mg/kg/d) for 3 days
Number of subjects: 60
Study 26007314 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose ibuprofen (10-5-5 mg/kg/d) for 3 days
Number of subjects: 60
Study 23339736 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial maxillary expansion followed by U-bow activator therapy
Number of subjects: 66
Study 23339736 — intervention group
Group type: COMPARATOR
Intervention: Normal growth effects (Control)
Number of subjects: 66
Study 23274323 — intervention group
Group type: EXPERIMENTAL
Intervention: Campath 30 mg + methylprednisolone 500 mg followed by TAC monotherapy (Group A)
Number of subjects: 30
Study 23274323 — intervention group
Group type: COMPARATOR
Intervention: ATG 8 mg/kg with TAC + MMF + steroids (Group B)
Number of subjects: 30
Study 19641203 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine group (10 subjects)
Number of subjects: 15
Study 19641203 — intervention group
Group type: COMPARATOR
Intervention: Control group (5 subjects)
Number of subjects: 15
Study 17383777 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 445
Study 17383777 — intervention group
Group type: COMPARATOR
Intervention: COPD, heart failure, and falls
Number of subjects: 445
Study 17383777 — intervention group
Group type: COMPARATOR
Intervention: All study populations
Number of subjects: 445
Study 15577470 — intervention group
Group type: EXPERIMENTAL
Intervention: Metasul articulations
Number of subjects: 582
Study 15577470 — intervention group
Group type: COMPARATOR
Intervention: Control ceramic‐on‐polyethylene group
Number of subjects: 582
Study 10668851 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 (8 microg/kg)
Number of subjects: 12
Study 9071476 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic estrogen-gestagen replacement therapy (ERT)
Number of subjects: 91
Study 9071476 — intervention group
Group type: COMPARATOR
Intervention: Untreated (Control)
Number of subjects: 91
Study 8374882 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of oral cryotherapy
Number of subjects: 178
Study 8374882 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 minutes of oral cryotherapy
Number of subjects: 178
Study 3522529 — intervention group
Group type: EXPERIMENTAL
Intervention: Timentin and tobramycin
Number of subjects: 151
Study 3522529 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin and tobramycin
Number of subjects: 151
Study 31702385 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led individualized self-management program (NISMP)
Number of subjects: 112
Study 31702385 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study 29144886 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive care among individuals with chronic lower respiratory disease
Number of subjects: 3307
Study 29144886 — intervention group
Group type: COMPARATOR
Intervention: Usual care among individuals with chronic lower respiratory disease
Number of subjects: 3307
Study 29144886 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive care among individuals without chronic lower respiratory disease
Number of subjects: 3307
Study 29144886 — intervention group
Group type: COMPARATOR
Intervention: Usual care among individuals without chronic lower respiratory disease
Number of subjects: 3307
Study 29144886 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted analysis for proactive group among individuals with chronic lower respiratory disease
Number of subjects: 3307
Study 29144886 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted analysis for proactive group among individuals without chronic lower respiratory disease
Number of subjects: 3307
Study 27572401 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine triphosphate (FTC-TP) in dried blood spots (DBS)
Number of subjects: 445
Study 27572401 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF-FTC dosing
Number of subjects: 445
Study 27572401 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired plasma-DBS samples
Number of subjects: 445
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinovirus infection
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza A infection
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenovirus infection
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Human coronavirus OC43/229E infection
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Parainfluenza virus 3 infection
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Parainfluenza virus 1 infection
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual infections
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: ILI occurrence
Number of subjects: 1038
Study 25413828 — intervention group
Group type: EXPERIMENTAL
Intervention: MERS-CoV detection
Number of subjects: 1038
Study 22333216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation (n=30, complete ablation)
Number of subjects: 112
Study 22333216 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (n=34, complete ablation)
Number of subjects: 112
Study 20653637 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin-assisted treatment (HAT)
Number of subjects: 0
Study 20653637 — intervention group
Group type: COMPARATOR
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 0
Study 20653637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing prostitution
Number of subjects: 0
Study 18724121 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper cervicothoracic sympathetic block (CTGB)
Number of subjects: 28
Study 18724121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CTGB)
Number of subjects: 28
Study 15998677 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/d
Number of subjects: 18569
Study 15998677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18569
Study 12654665 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin 4 mg/kg
Number of subjects: 24
Study 12654665 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin 6 mg/kg
Number of subjects: 24
Study 12654665 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin 8 mg/kg
Number of subjects: 24
Study 12654665 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 10513756 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward stepwise selection with 8 predictors
Number of subjects: 40830
Study 10513756 — intervention group
Group type: COMPARATOR
Intervention: No selection applied
Number of subjects: 40830
Study 8851637 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 0
Study 8851637 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 0
Study 2228356 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel revolution rate on a bicycle wind-loaded simulator
Number of subjects: 40
Study 2228356 — intervention group
Group type: COMPARATOR
Intervention: Different FMR machines
Number of subjects: 40
Study 7378257 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 7378257 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 12
Study 30775139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone
Number of subjects: 15
Study 30775139 — intervention group
Group type: COMPARATOR
Intervention: Intralesional verapamil
Number of subjects: 15
Study 30428890 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling along Downtown route
Number of subjects: 38
Study 30428890 — intervention group
Group type: COMPARATOR
Intervention: Cycling along Residential route
Number of subjects: 38
Study 30428890 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Downtown vs Residential routes
Number of subjects: 38
Study 27261989 — intervention group
Group type: EXPERIMENTAL
Intervention: Kirtan Kriya meditation (KK) program
Number of subjects: 60
Study 27261989 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening (ML) program
Number of subjects: 60
Study 25076428 — intervention group
Group type: EXPERIMENTAL
Intervention: Meglumine antimoniate (MA) treatment
Number of subjects: 57
Study 22731734 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg)
Number of subjects: 24
Study 22731734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 20407903 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced MRA using Gd-DOTA (intravenous bolus 0.1 mmol/kg)
Number of subjects: 92
Study 20407903 — intervention group
Group type: COMPARATOR
Intervention: Unenhanced MRA
Number of subjects: 92
Study 20407903 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced MRA using Gd-DOTA
Number of subjects: 92
Study 18046999 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% mitomycin C (MMC) applied topically for 2 minutes after PRK
Number of subjects: 28
Study 18046999 — intervention group
Group type: COMPARATOR
Intervention: Standard PRK (no MMC)
Number of subjects: 28
Study 16223398 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 150 microg
Number of subjects: 150
Study 16223398 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine 1 microg/kg
Number of subjects: 150
Study 16223398 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (Control group)
Number of subjects: 150
Study 11887511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCL)
Number of subjects: 40
Study 11887511 — intervention group
Group type: COMPARATOR
Intervention: Deionized distilled water (DDW)
Number of subjects: 40
Study 9790199 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified transection
Number of subjects: 83
Study 9790199 — intervention group
Group type: COMPARATOR
Intervention: Classic transection
Number of subjects: 83
Study 9790199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study 7630694 — intervention group
Group type: EXPERIMENTAL
Intervention: 84 J/oz formula
Number of subjects: 52
Study 7630694 — intervention group
Group type: EXPERIMENTAL
Intervention: 100.8 J/oz formula
Number of subjects: 52
Study 7630694 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulas
Number of subjects: 52
Study 2702793 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.15 mg/kg)
Number of subjects: 11
Study 2702793 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg)
Number of subjects: 11
Study 2702793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 337078 — intervention group
Group type: EXPERIMENTAL
Intervention: Frubiase Calcium forte
Number of subjects: 80
Study 337078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 7030120 — intervention group
Group type: EXPERIMENTAL
Intervention: Disoprofol 1.2 mg/kg
Number of subjects: 0
Study 7030120 — intervention group
Group type: EXPERIMENTAL
Intervention: Disoprofol 3 mg/kg
Number of subjects: 0
Study 7030120 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone 1 mg/kg
Number of subjects: 0
Study 7030120 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone 2 mg/kg
Number of subjects: 0
Study 7030120 — intervention group
Group type: EXPERIMENTAL
Intervention: Disoprofol
Number of subjects: 0
Study 7030120 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 0
Study 31897405 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg
Number of subjects: 50
Study 31897405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 28303758 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g n‐3 polyunsaturated fatty acids (PUFAs) per day
Number of subjects: 145
Study 28303758 — intervention group
Group type: COMPARATOR
Intervention: 3 g olive oil per day (control)
Number of subjects: 145
Study 27089418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger extract (3g daily for 1 month)
Number of subjects: 69
Study 27089418 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch capsule)
Number of subjects: 69
Study 22515652 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy using maxacalcitol lotion (weekdays) and betamethasone butyrate propionate lotion (weekends) for 4 weeks
Number of subjects: 37
Study 22515652 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy using maxacalcitol lotion (weekdays) and betamethasone butyrate propionate lotion (weekends) for 8 weeks
Number of subjects: 37
Study 22515652 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with maxacalcitol lotion after combination therapy
Number of subjects: 37
Study 23234560 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based arm ergometry aerobic exercise programme (moderate intensity 50-70% HRMax) for eight weeks
Number of subjects: 0
Study 23234560 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 20959428 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac potassium for oral solution (50 mg)
Number of subjects: 690
Study 20959428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study 17503161 — intervention group
Group type: COMPARATOR
Intervention: Standard group (control)
Number of subjects: 180
Study 17503161 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone group
Number of subjects: 180
Study 17503161 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-patient group
Number of subjects: 180
Study 17503161 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled telephone and outpatient group
Number of subjects: 180
Study 17503161 — intervention group
Group type: COMPARATOR
Intervention: Non-advised smokers
Number of subjects: 180
Study 17503161 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall wound infection rate
Number of subjects: 180
Study 15758600 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic agents
Number of subjects: 0
Study 15758600 — intervention group
Group type: COMPARATOR
Intervention: Selective thrombophilia screening
Number of subjects: 0
Study 15758600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acquired thrombophilia
Number of subjects: 0
Study 15758600 — intervention group
Group type: EXPERIMENTAL
Intervention: Heritable thrombophilias
Number of subjects: 0
Study 12077953 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation of religious affiliation
Number of subjects: 23
Study 12077953 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion of religious beliefs
Number of subjects: 23
Study 12077953 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training on religious awareness
Number of subjects: 23
Study 10211496 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins (enoxaparin)
Number of subjects: 320
Study 10211496 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 320
Study 7886461 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 50
Study 7886461 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment with a newly developed boot
Number of subjects: 50
Study 2179477 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFPT X 12 plus continuous tamoxifen
Number of subjects: 803
Study 2179477 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFPT X 12
Number of subjects: 803
Study 2179477 — intervention group
Group type: COMPARATOR
Intervention: CMFPT X 4
Number of subjects: 803
Study 26371 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 26371 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 12
Study 26371 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 12
Study 26371 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 12